These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6874596)

  • 21. Induction of the bioconversion of leucomycins by glucose in a producing strain.
    Omura S; Miyazawa J; Takeshima H; Kitao C; Aizawa M
    J Antibiot (Tokyo); 1977 Feb; 30(2):192-3. PubMed ID: 849921
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis of 4'-deoxymycaminosyl tylonolide.
    Tanaka A; Tsuchiya T; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1374-6. PubMed ID: 7309633
    [No Abstract]   [Full Text] [Related]  

  • 23. Bioconversion of leucomycins and its regulation by butyrate in a producing strain.
    Omura S; Miyazawa J; Takeshima H; Kitao C; Atsumi K
    J Antibiot (Tokyo); 1976 Oct; 29(10):1131-3. PubMed ID: 994332
    [No Abstract]   [Full Text] [Related]  

  • 24. Ammonium ion suppresses the biosynthesis of tylosin aglycone by interference with valine catabolism in Streptomyces fradiae.
    Omura S; Tanaka Y; Mamada H; Masuma R
    J Antibiot (Tokyo); 1983 Dec; 36(12):1792-4. PubMed ID: 6662823
    [No Abstract]   [Full Text] [Related]  

  • 25. Bioconversion and biosynthesis of 16-membered macrolide antibiotic, tylosin, using enzyme inhibitor: cerulenin.
    Omura S; Kitao C; Miyazawa J; Imai H; Takeshima H
    J Antibiot (Tokyo); 1978 Mar; 31(3):254-6. PubMed ID: 649519
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the effects of 3-acetyl-4"-isovaleryltylosin against multiple-drug resistant strains of Staphylococcus aureus.
    Tsuchiya M; Suzukake K; Hori M; Sawa T; Takeuchi T; Umezawa H; Okamoto R; Nomura H; Tsunekawa H; Inui T
    J Antibiot (Tokyo); 1981 Mar; 34(3):305-12. PubMed ID: 7275812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New derivatives of tylosin. IV. Dihydro and tetrahydro desmycosin oximes.
    Naranda A; Lopotar N
    J Antibiot (Tokyo); 1999 Jan; 52(1):68-70. PubMed ID: 10092201
    [No Abstract]   [Full Text] [Related]  

  • 28. Syntheses of derivatives of 4'-deoxymycaminosyl tylonolide and mycaminosyl tylonolide modified AT C-23.
    Tanaka A; Tsuchiya T; Umezawa S; Hamada M; Umezawa H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1377-80. PubMed ID: 7309634
    [No Abstract]   [Full Text] [Related]  

  • 29. Valine as a precursor of n-butyrate unit in the biosynthesis of macrolide aglycone.
    Omura S; Tsuzuki K; Tanaka Y; Sakakibara H; Aizawa M; Lukacs G
    J Antibiot (Tokyo); 1983 May; 36(5):614-6. PubMed ID: 6874580
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemical modification of tylosin: synthesis of amino derivatives at C-20 position of tylosin and demycarosyltylosin.
    Matsubara H; Inokoshi J; Nakagawa A; Tanaka H; Omura S
    J Antibiot (Tokyo); 1983 Dec; 36(12):1713-21. PubMed ID: 6662813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and identification of a metabolite of rosaramicin in human urine.
    Lin C; Puar MS; Schuessler D; Prananik BN; Symchowicz S
    Drug Metab Dispos; 1984; 12(1):51-6. PubMed ID: 6141912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of dedesosaminyl 5-O-mycaminosyl-10,11-dihydromycinamicin IV.
    Lotvin J; Puar MS; Patel M; Lee BK; Schumacher D; Waitz JA
    J Antibiot (Tokyo); 1982 Oct; 35(10):1407-8. PubMed ID: 7174525
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro antibacterial properties of EL-870, a new semi-synthetic macrolide antibiotic.
    Ose EE
    J Antibiot (Tokyo); 1987 Feb; 40(2):190-4. PubMed ID: 3570967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New derivatives of tylosin: chemical and electrochemical oxidation products of desmycosin.
    Mandić Z; Naranda A; Novak P; Brajsa K; Derek M; Iveković D
    J Antibiot (Tokyo); 2002 Sep; 55(9):807-13. PubMed ID: 12458770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of dietary copper and tylosin and subsequent withdrawal on growth, hematology and tissue residues of growing-finishing pigs.
    Lillie RJ; Frobish LT; Steele NC; Graber G
    J Anim Sci; 1977 Jul; 45(1):100-7. PubMed ID: 885815
    [No Abstract]   [Full Text] [Related]  

  • 36. Enzymatic phosphorylation of macrolide antibiotics.
    Wiley PF; Baczynskyj L; Dolak LA; Cialdella JI; Marshall VP
    J Antibiot (Tokyo); 1987 Feb; 40(2):195-201. PubMed ID: 3570968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deepoxidation of 16-membered epoxyenone macrolide antibiotics. III. In vitro and in vivo evaluation of deepoxidation products of carbomycin A, deltamycin A1, 4"-phenylacetyldeltamycin, angolamycin and rosamicin.
    Sakamoto M; Mutoh Y; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1984 Feb; 37(2):130-5. PubMed ID: 6706849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and evaluation of 3,4''-ester derivatives of 16-membered macrolide antibiotics related to tylosin.
    Kirst HA; Debono M; Willard KE; Truedell BA; Toth JE; Turner JR; Berry DR; Briggs BB; Fukuda DS; Daupert VM
    J Antibiot (Tokyo); 1986 Dec; 39(12):1724-35. PubMed ID: 3818446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pharmacokinetic analysis of tylosin in the normal dog.
    Weisel MK; Powers JD; Powers TE; Baggot JD
    Am J Vet Res; 1977 Feb; 38(2):273-5. PubMed ID: 842925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Components of the macrolide binding site on the ribosome.
    Tejedor F; Ballesta JP
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():53-62. PubMed ID: 4055551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.